Market Overview

UPDATE: Deutsche Bank Upgrades Mednax to Hold, Raises PT

Share:
Related MD
After Rounds Of Financing, Is Healthcare M&A Picking Up?
Benzinga's Top Initiations

In a report published Friday, Deutsche Bank upgraded its rating on Mednax (NYSE: MD) from Sell to Hold, and raised its price target from $65.00 to $76.00.

Deutsche Bank noted, “MD's last two quarters have significantly allayed our concerns about a steeper slow-down in NICU trends. The combination of better-than-expected NICU volumes and stronger margins force us to reconsider our more cautious view on MD's earnings power. We move to Hold (from Sell), and raise our PT to $76 ($65) on higher estimates and our year-end process to roll-forward valuations off the new out-year (2014).”

Mednax closed on Thursday at $73.41.

Latest Ratings for MD

DateFirmActionFromTo
Oct 2015SunTrust Robinson HumphreyMaintainsNeutral
Sep 2015Mizuho SecuritiesInitiates Coverage onBuy
Sep 2015Mizuho SecuritiesInitiates Coverage onBuy

View More Analyst Ratings for MD
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Analyst Ratings

 

Related Articles (MD)

View Comments and Join the Discussion!

Get Benzinga's Newsletters